Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone.

Tohen M, Chengappa KN, Suppes T, Baker RW, Zarate CA, Bowden CL, Sachs GS, Kupfer DJ, Ghaemi SN, Feldman PD, Risser RC, Evans AR, Calabrese JR.

Br J Psychiatry. 2004 Apr;184:337-45.

PMID:
15056579
2.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
3.

A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.

Soares-Weiser K, Bravo Vergel Y, Beynon S, Dunn G, Barbieri M, Duffy S, Geddes J, Gilbody S, Palmer S, Woolacott N.

Health Technol Assess. 2007 Oct;11(39):iii-iv, ix-206. Review.

4.

Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.

[No authors listed]

Prescrire Int. 2005 Aug;14(78):140-2.

PMID:
16106596
5.

Olanzapine in long-term treatment for bipolar disorder.

Cipriani A, Rendell JM, Geddes J.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004367. doi: 10.1002/14651858.CD004367.pub2. Review.

PMID:
19160237
6.

Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.

Katagiri H, Takita Y, Tohen M, Higuchi T, Kanba S, Takahashi M.

Curr Med Res Opin. 2012 May;28(5):701-13. doi: 10.1185/03007995.2012.666961. Epub 2012 Apr 10.

PMID:
22356118
7.

Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.

Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, Koukopoulos A, Cassano GB, Grunze H, Licht RW, Dell'Osso L, Evans AR, Risser R, Baker RW, Crane H, Dossenbach MR, Bowden CL.

Am J Psychiatry. 2005 Jul;162(7):1281-90.

PMID:
15994710
8.

Predictors of relapse or recurrence in bipolar I disorder.

Degenhardt EK, Gatz JL, Jacob J, Tohen M.

J Affect Disord. 2012 Feb;136(3):733-9. doi: 10.1016/j.jad.2011.09.051. Epub 2011 Oct 28.

PMID:
22036802
9.

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.

Tohen M, Chengappa KN, Suppes T, Zarate CA Jr, Calabrese JR, Bowden CL, Sachs GS, Kupfer DJ, Baker RW, Risser RC, Keeter EL, Feldman PD, Tollefson GD, Breier A.

Arch Gen Psychiatry. 2002 Jan;59(1):62-9.

PMID:
11779284
10.

Polytherapy in bipolar disorder.

Lin D, Mok H, Yatham LN.

CNS Drugs. 2006;20(1):29-42. Review.

PMID:
16396522
11.

Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.

Maina G, Albert U, Salvi V, Mancini M, Bogetto F.

J Affect Disord. 2007 Apr;99(1-3):247-51. Epub 2006 Oct 23.

PMID:
17056122
12.

Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial.

BALANCE investigators and collaborators, Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ, Morriss R, Alder N, Juszczak E.

Lancet. 2010 Jan 30;375(9712):385-95. doi: 10.1016/S0140-6736(09)61828-6. Epub 2010 Jan 19.

PMID:
20092882
13.

Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania.

Baker RW, Brown E, Akiskal HS, Calabrese JR, Ketter TA, Schuh LM, Trzepacz PT, Watkin JG, Tohen M.

Br J Psychiatry. 2004 Dec;185:472-8.

14.

A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.

Bridle C, Palmer S, Bagnall AM, Darba J, Duffy S, Sculpher M, Riemsma R.

Health Technol Assess. 2004 May;8(19):iii-iv, 1-187. Review.

15.

Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.

Sussman N, Mullen J, Paulsson B, Vågerö M.

J Affect Disord. 2007;100 Suppl 1:S55-63. Epub 2007 Mar 26.

PMID:
17383736
16.

Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.

Tohen M, Calabrese JR, Sachs GS, Banov MD, Detke HC, Risser R, Baker RW, Chou JC, Bowden CL.

Am J Psychiatry. 2006 Feb;163(2):247-56.

PMID:
16449478
17.

Variables as mediators or moderators in predicting relapse to any type of mood episode in a bipolar maintenance study.

Tohen M, Wang WV, Leboyer M, Jen KY.

J Clin Psychiatry. 2012 Jul;73(7):e913-7. doi: 10.4088/JCP.10m06737.

PMID:
22901362
18.
19.

Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.

Ketter TA, Houston JP, Adams DH, Risser RC, Meyers AL, Williamson DJ, Tohen M.

J Clin Psychiatry. 2006 Jan;67(1):95-101.

PMID:
16426094
20.

Self-harm, Unintentional Injury, and Suicide in Bipolar Disorder During Maintenance Mood Stabilizer Treatment: A UK Population-Based Electronic Health Records Study.

Hayes JF, Pitman A, Marston L, Walters K, Geddes JR, King M, Osborn DP.

JAMA Psychiatry. 2016 Jun 1;73(6):630-7. doi: 10.1001/jamapsychiatry.2016.0432.

PMID:
27167638

Supplemental Content

Support Center